Patient Guide: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 51 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04123795
Status: 🟢 Enrolling Now
Condition: Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis
Phase: PHASE3

Where You Can Participate

This study is available at 51 locations across the country.

Top locations include:
  • • Auburn, Alabama
  • • Phoenix, Arizona
  • • Anaheim, California
  • • And 48 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis - Join Clinical Trial NCTNCT04123795

How to Join This Clinical Trial - NCTNCT04123795

Learn how to participate in this PHASE3 trial studying an investigational therapy for Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04123795 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 51 locations. Find a study site near you:

Clinical Research Site

Auburn, Alabama 36832 - United States

Status: WITHDRAWN

Clinical Research Site

Phoenix, Arizona 85006 - United States

Status: COMPLETED

Clinical Research Site

Anaheim, California 92804 - United States

Status: WITHDRAWN

Clinical Research Site

Fountain Valley, California 92708 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90045 - United States

Status: RECRUITING

Clinical Research Site

Thousand Oaks, California 91320 - United States

Status: RECRUITING

Clinical Research Site

Aurora, Colorado 80012 - United States

Status: WITHDRAWN

Clinical Research Site

Boca Raton, Florida 33428 - United States

Status: RECRUITING

Clinical Research Site

Hialeah, Florida 33016 - United States

Status: RECRUITING

Clinical Research Site

Jacksonville, Florida 32256 - United States

Status: RECRUITING

And 41 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis, Mixed Guttate/Plaque Psoriasis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships